HCW Biologics Inc. Other Income
HCW Biologics Inc. (HCWB) reported Other Income of $304.74 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2023-03-28
- HCW Biologics Inc. other income for fiscal 2022 was $304.74K, a 39.70% decline from fiscal 2021.
- HCW Biologics Inc. other income for fiscal 2021 was $505.37K.
| Period end | Other Income 12 month |
|---|---|
| 2022-12-31 | $304.74K 10-K · filed 2023-03-28 |
| 2021-12-31 | $505.37K 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |